Scarica l'app Stockscreener
0.29
25.54%
0.059
Dopo l'orario di chiusura:
.30
0.01
+3.45%
AEON Biopharma Inc. Borsa (AEON) Ultime notizie
12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com
$AEON Biopharma (AEON.US)$ interesting. got it marked from 2025 not sure why lmao - Moomoo
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
The rocket is about to launch 😘 - Moomoo
$AEON Biopharma (AEON.US)$ - Moomoo
Laidlaw initiates Aeon Biopharma stock coverage with buy rating By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com
AEON Biopharma, Inc. Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of Abp-450 to Botox - marketscreener.com
AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX - marketscreener.com
BOTOX and ABP-450 each fell to about half strength by day 14 - Stock Titan
Laidlaw initiates Aeon Biopharma stock coverage with buy rating - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference - The Manila Times
AEON Biopharma to Host Investor Meetings at Lake Street Capital Markets’ 10th Annual BIG10 Conference - Quiver Quantitative
Insider Purchase: 10% Owner at $AEON Buys 1,150,000 Shares - Moomoo
AEON Biopharma names Paul Lee as acting chief regulatory officer By Investing.com - Investing.com Nigeria
A Former FDA Neuroscience Deputy Will Guide AEON’s BOTOX Biosimilar - Stock Titan
Aeon Biopharma director Timothy Lynch buys $243,455 in stock - Investing.com India
Timothy Lynch (NASDAQ: AEON) owns 13% and holds blocked warrants - Stock Titan
AEON Reports New Data on Botox Biosimilar - Orange County Business Journal
Lake Street Maintains AEON Biopharma(AEON.US) With Buy Rating, Maintains Target Price $1 - Moomoo
AEON Flat on BOTOX Developments - Baystreet.ca
META_TITLE_QUOTE - Yahoo Finance
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - The Manila Times
AEON Biopharma (AEON) Steadies at $0.28 as Key Support HoldsVolume Gap - vinanet.vn
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution - Investing.com
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution By Investing.com - Investing.com UK
AEON Biopharma (AEON) Holds Above $0.27 Support as Shares Edge Up 1.66%Extension Target - vinanet.vn
AEON Q4 2025 Earnings: Wider-than-Expected Loss of -$0.42 per Share as Revenue Remains Absent - vinanet.vn
H.C. Wainwright Maintains AEON Biopharma(AEON.US) With Buy Rating, Cuts Target Price to $1.2 - Moomoo
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma Q2 EPS $(0.02) beats $(0.12) estimate - scanx.trade
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program - TipRanks
AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended - TradingView
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
AEON BIOPHARMA INC Q2 EBIT USD -5.919 MILLION - Moomoo
Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards - The Manila Times
Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AEON Biopharma Regains NYSE American Listing Compliance - TipRanks
AEON Biopharma Regains NYSE American Compliance After Completing Public Offering - Quiver Quantitative
AEON Biopharma (NYSE American: AEON) lifts .BC indicator after $13.6M equity raise - Stock Titan
AEON Q4 2025 Earnings: Wider Loss of -$0.42 Per Share Overshadowed by 14.81% Stock SurgeHealthcare Earnings Report - vinanet.vn
AEON Q4 2025 Earnings: Deep EPS Miss Overshadowed by 14.81% Share RallyPeak Earnings Alert - vinanet.vn
AEON Biopharma, Inc. Revenue Breakdown – AMEX:AEON - TradingView
Aeon Biopharma Inc (AEON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AEON|Aeon Biopharma Inc|Price:0.257|Chg%:+0.006 - TradingKey
Aeon Biopharma Inc (AEON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aeon Biopharma Inc (AEON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aeon Biopharma Inc (AEON) Income Statement - TradingKey
Aeon Biopharma Inc (AEON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bitget Launchpool adds AEON (AEON) with 1.1M in Token Rewards - GlobeNewswire Inc.
Aeon Biopharma Inc (AEON) Balance Sheet - TradingKey
Aeon Biopharma Inc (AEON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aeon Biopharma Inc (AEON) Cash Flow - TradingKey
AEON|Aeon Biopharma Inc|Price:0.241|Chg%:-0.014 - TradingKey
AEON Biopharma, Inc. Revenue Breakdown – BOATS:AEON - TradingView
Aeon Biopharma Inc (AEON) Institutional Confidence - TradingKey
Aeon Biopharma Inc (AEON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
3.04%
Capitalizzazione:
|
Volume (24 ore):